Lilac CEO: It is expected that Lilac's new weight loss drug will be approved in early 2026

On January 13th, Jinshi Data reported that Eli Lilly CEO Dave Ricks stated that the company expects its experimental weight-loss drug to be approved as early as the beginning of 2026. Dave Ricks said in an interview that Lilly expects data on the drug, called orforglipron, to be released before mid-2025. He also said that the drug is more convenient for patients and easier to produce on a large scale.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)